Vitalhub (TSE:VHI - Get Free Report) had its target price upped by investment analysts at TD Securities from C$15.00 to C$16.00 in a research note issued on Monday,BayStreet.CA reports. The brokerage presently has a "buy" rating on the stock. TD Securities' price objective indicates a potential upside of 22.14% from the company's current price.
Several other research analysts have also commented on VHI. Scotiabank raised their price target on Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a research report on Friday, June 20th. Raymond James Financial raised their price target on Vitalhub from C$13.50 to C$14.00 and gave the stock an "outperform" rating in a research report on Friday, June 20th. National Bank Financial upgraded Vitalhub to a "strong-buy" rating in a research report on Monday, June 9th. Finally, National Bankshares set a C$14.00 price target on Vitalhub and gave the stock an "outperform" rating in a research report on Tuesday, June 10th. Six analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Vitalhub has a consensus rating of "Buy" and a consensus target price of C$13.58.
Check Out Our Latest Stock Analysis on VHI
Vitalhub Stock Performance
Shares of VHI stock traded down C$0.86 during trading hours on Monday, reaching C$13.10. The company had a trading volume of 254,824 shares, compared to its average volume of 140,738. The company has a market capitalization of C$708.61 million, a price-to-earnings ratio of 213.07, a PEG ratio of 1.18 and a beta of 1.26. Vitalhub has a 12-month low of C$7.62 and a 12-month high of C$14.64. The stock has a fifty day moving average of C$11.84 and a 200-day moving average of C$10.87.
Insider Activity
In related news, Director Francis Nelson Shen purchased 25,000 shares of the stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average price of C$10.23 per share, with a total value of C$255,750.00. Insiders own 18.57% of the company's stock.
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access